Details for New Drug Application (NDA): 012155
✉ Email this page to a colleague
NDA 012155 describes RELA, which is a drug marketed by Schering and Smithkline Beecham and is included in two NDAs. Additional details are available on the RELA profile page.
The generic ingredient in RELA is nabumetone. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nabumetone profile page.
The generic ingredient in RELA is nabumetone. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nabumetone profile page.
Summary for 012155
| Tradename: | RELA |
| Applicant: | Schering |
| Ingredient: | carisoprodol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012155
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 350MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
